Last updated on February 2018

Efficacy of Olmesartan on Cerebral Glucose Metabolism Vascular Inflammation and Adipose Tissue

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Efficacy of Olmesartan on Cerebral Glucose Metabolism in Essential Hypertension
  • Age: Between 20 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Written informed consent obtained
  • Male and female subjects aged 20 years or older at informed consent
  • Essential hypertension who had never received angiotensin II receptor antagonists and calcium channel blockers

Exclusion Criteria:

  • Secondary hypertension or malignant hypertension
  • Diabetes mellitus
  • History or evidence of a stroke
  • Hepatic or hematologic abnormality
  • Mild Cognitive Impairment or Dementia
  • Serum potassium level 5.5 mEq/L
  • Serum creatinine level 3.0 mg/dL
  • Acute or chronic disease
  • Allergy to any drugs
  • Pregnancy

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.